What’s Up with Vascular Biogenics Ltd (NASDAQ:VBLT)

Vascular Biogenics Ltd (NASDAQ:VBLT) is moving higher slightly in pre-market trading on Thursday.

Market Action

As of 7:54, VBLT stock is trading up by 0.50% to $2.23 in the pre-market session with 800 shares have traded hands.

VBLT Announces News

VBL Therapeutics to Provide an Update on the OVAL Phase 3 Registration Enabling Study of VB-111 in Ovarian Cancer at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

  • VBLT announced that a poster providing an update on the OVAL Phase 3 registration enabling clinical trial of VB-111 in ovarian cancer will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.
  • Title: Clinical Trial in Progress: Pivotal Study of VB-111 Combined with Paclitaxel vs. Paclitaxel for Treatment of Platinum-Resistant Ovarian Cancer (OVAL, VB-111-701/GOG-3018)

“We are encouraged by the continued progress of the OVAL clinical trial, which remains on track,” said Dror Harats, M.D., CEO of VBL Therapeutics. “The poster will provide an important update on the trial.”

Trader Notes

Share Information

SHARES OUTSTANDING60.28 M
SHARE FLOAT (%)44.13 M (73.20%)
% HELD BY INSTITUTIONS8.16

Recent Stock Performance

5-DAY PERF.+14.43%
1-MONTH PERF.+24.72%
3-MONTH PERF.-12.94%
6-MONTH PERF.+86.55%
YTD PERF.+17.46%
1-YEAR PERF.+88.14%

Moving Averages

+/- EMA(20)2.03 (+9.36%)
+/- SMA(50)1.98 (+12.12%)
+/- SMA(200)1.71 (+29.82%)

Pivot Points

NameS3S2S1Pivot PointsR1R2R3
Classic2.01002.06002.14002.19002.27002.32002.4000
Fibonacci2.06002.10972.14032.19002.23972.27032.3200

Technical Indicators

SymbolValueResultSymbolValueResult
ADX18.3855NeutralATR140.1798
CCI20141.5349BuyChaikin Money Flow0.1315Buy
MACD0.0301BuyMoney Flow Index67.8311Buy
ROC4.2254BuyRSI61.4189Buy
STOCH (14,3)77.1930BuySTOCH RSI1.0000OverBought
UO49.2731SellWilliams %R-22.8070Neutral

Related Posts

About The Author